Serum antibodies to collagen type IV and development of diabetic vascular complications in children with type 1 (insulin-dependent) diabetes mellitus: A longitudinal study

Vascular Pharmacology

Volumn 38, Issue 3, 2002, Pages 143-147

  Nicoloff, G ^a   Baydanoff, S ^a   Petrova, Ch ^a   Christova, P ^a  

^a MEDICAL UNIVERSITY PLEVEN   (Bulgaria)

Author keywords

Antibodies (IgG, IgM and IgA) to collagen type IV; Diabetic microvascular complications; ELISA

Indexed keywords

ADVANCED GLYCATION END PRODUCT; COLLAGEN TYPE 4; HEMOGLOBIN A1C; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; TRIACYLGLYCEROL;

ADOLESCENT; ANTIBODY BLOOD LEVEL; ARTICLE; BASEMENT MEMBRANE; BIOLOGICAL MONITORING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC MICROANGIOPATHY; DISEASE COURSE; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MICROALBUMINURIA; PRIORITY JOURNAL;

ADOLESCENT; ANALYSIS OF VARIANCE; CHILD; CHILD, PRESCHOOL; COLLAGEN TYPE IV; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LONGITUDINAL STUDIES; MALE;

EID: 0036524582     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1537-1891(02)00214-8     Document Type: Article

References (32)

1. Airaksinen K.E.J., Salmela P.I., Linnaluto M.K., Ikaheimo M.J., Ahola K., Ryhanen L.J. Diminished arterial elasticity in diabetes: association with fluorescent advanced glycosylation end products in collagen. Cardiovasc. Res. 27:1993;942-945.
2. Alland A., Hartmann D., Loupy G., Lechevalier D., Ville G., Cotisson A., Ulrich J. Etude de la fibronectine et ducollagene de type IV plasmatiques chez le diabetique. Pathol. Biol. 32:1984;115-121.
3. Balashova L.M., Zaitseva N.S., Teplinskaia L.E., Koval'chuk L.V., Gankovskaia L.V., Obraztsova E.N., Aronskind M.S. Antitela k kollagenu II i IV tipov, faktor nekroza opukholi al'fa i tsirkuliruiushchie immunnye kompleksy v sleze i syvorotke krovi u bol'nykh s razlichnymi stadiiami diabeticheskoi angioretinopatii. Vestn Oftal'mol. 116:2000;31-34.
4. Brownlee M. Glycation products and the pathogenesis of diabetic complications. Diabetes Care. 15:1992;1835-1843.
5. Brownlee M., Pongar S., Cerami A. Covalent attachment of soluble proteins by nonenzymatically glycosylated collagen. J. Exp. Med. 158:1983;1739-1744.
6. Cohen M., Ziyadeh F. Amadori glucose adducts modulate mesangial cell growth and collagen gene expression. Kidney Int. 45:1994;475-484.
7. Dahlquist G., Rudberg S. The prevalence of microalbuminuria in diabetic children and adolescents and its relation to puberty. Acta Pediatr. Scand. 76:1987;795-800.
8. Daskalova M., Taskov H., Dimitrova E., Baydanoff S. Humoral and cellular immune response to elastin in patients with systemic sclerosis. Autoimmunity. 25:1997;233-241.
9. Fikui M., Nakamura T., Ebinara I., Shirato I., Tomino Y., Koide H. ECM gene expression and its modulation by insulin in diabetic rats. Diabetes. 41:1992;1520-1527.
10. Gay S., Ward W., Gay R., Miller E. Autoantibodies to basement membrane collagen. Epidermolysis bullosa simplex versus bullous pemphigoid. J. Cutaneous Pathol. 7:1980;315-317.
11. Inomata S., Iton M., Sato T. Difference of serum levels of type IV collagen 7S between early or overt nephropathy and nondiabetic renal disease in diabetic patients with micro- or macroalbuminuria. Nephron. 73:1996;601-605.
12. Ishimura E., Nishizawa Y., Shoji S., Mori H. Serum type III, IV collagens and TIMP in patients with type II diabetes mellitus. Life Sci. 58:1996;1331-1337.
13. Klein R., Klein B.E.K., Moss S.E., Davis M.D., DeMets D.L. The Wisconsin epidemiological study of diabetic retinopathy: II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch. Ophthalmol. 102:1984;520-526.
14. Kuhn K. Basement membrane (Type IV) collagen. Matrix Biol. 14:1994;439-445.
15. Mackel A., DeLustro F., Harper F., LeRoy E. Antibodies to collagen in scleroderma. Arthritis Rheum. 25:1982;522-531.
16. Mathiesen E.R., Saurbrey N., Hommel E., Parving H.-H. Prevalence of microalbuminuria in children with type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 29:1986;640-643.
17. Matsumoto E., Matsumoto G., Bessho H., Kikuoka H., Nanjo K. Serum concentrations of intact type IV collagen in diabetics. J. Diabetic Complications. 5:1991;189-190.
18. Moreland L., Gay R., Gay S. Collagen autoantibodies in patients with vasculitis and systemic lupus erythematosus. Clin. Immunol. Immunopathol. 60:1991;412-418.
19. Morgan K., Clague R., Collins I., Ayad S., Phinn S., Holt P. A longitudinal study of anticollagen antibodies in patients with rheumatoid arthritis. Arthritis Rheum. 32:1989;139-145.
20. Munro B. Correlation. Munro B., Visintainer M., Page E. Statistical Methods for Health Care Research. 1986;65-85 J.B. Lippincott, Philadelphia.
21. Nakamura T., Fikui M., Ebinara I., Osada S., Tomino Y., Koide H. Abnormal gene expression of matrix metaloproteinases and their inhibitor in glomeruli from diabetic rats. Renal Physiol. Biochem. 17:1994;316-325.
22. Nicoloff G., Baydanoff S., Stanimirova N., Petrova Ch., Christova P. An association of anti-elastin IgA antibodies with development of retinopathy in diabetic children. Gen. Pharmacol. 35:2000;83-87.
23. Nicoloff G., Baydanoff S., Stanimirova N., Petrova Ch., Christova P. Relationship between elastin-derived peptides and the development of microvascular complications. A longitudinal study in children with Type 1 (insulin-dependent) diabetes mellitus. Gen. Pharmacol. 35:2000;59-64.
24. Nicoloff G., Baydanoff S., Stanimirova N., Petrova Ch., Christova P. Detection of serum collagen type IV in children with Type 1 (insulin-dependent) diabetes mellitus - a longitudinal study. Pediatr. Diabetes. 2:2001;184-190.
25. Paulsson M. Basement membrane proteins: structure, assembly, and cellular interactions. Crit. Rev. Biochem. Mol. Biol. 27:1992;93-127.
26. Pugliese G., Prici F., Pesce C.M. Early, but not advanced, experimental glomerulopathy is reversed by pancreatic islet transplants. Correlation with glomerular extracellular matrix mRNA levels. Diabetes. 46:1997;1198-1206.
27. Reckelhoff J.F., Tygart V.L., Mitias M.M., Welcott J.L. STZ-induced diabetes results in decreased activity of glomerular cathepsin and metalloproteinase in rats. Diabetes. 42:1993;1425-1432.
28. Roy S., Calgiero E., Lorenzi M. Fibronectin, overexpression in retinal microvessels of patients with diabetes. Invest. Ophthalmol. Visual Sci. 37:1996;258-266.
29. Tsilbary E., Charonis A., Reger L., Wohlhueter R., Furcht L. The effect of non-enzymatic glucosylation on the binding of the main non-collagenous NC1 domain to type IV collagen. J. Biol. Chem. 263:1988;4302-4308.
30. 125I-radioimmunoassay. Arthritis Rheum. 26:1983;832-840.
31. Valkova D., Nicoloff G., Baydanoff S. Antibodies to collagen type I in sera of patients with systemic lupus erythematosus. Sci. Works Med. Univ. Pleven. XV(1):1995;12-13.
32. Yang C., Brinckmann J., Rui H., Vehring K., Lehmann H., Kekow J., Wolff H., Gross W., Muller P. Autoantibodies to cartilage collagens in relapsing polychondritis. Dermatol. Res. 285:1993;245-249.